Search results
Results from the WOW.Com Content Network
The Argus II retinal implant, manufactured by Second Sight Medical Products received market approval in the US in Feb 2013 and in Europe in Feb 2011, becoming the first approved implant. [6] The device may help adults with RP who have lost the ability to perceive shapes and movement to be more mobile and to perform day-to-day activities.
The second version, the Argus II, was designed to be smaller and easier to implant, and was co-invented by Mark Humayun of the USC Eye Institute, who had been involved in the clinical testing of the Argus I. [12] [11] The Argus II was first tested in Mexico in 2006, and then a 30-person clinical trial was conducted in 10 medical centers across ...
Humayun co-invented the Argus II retinal prosthesis, [23] a retinal implant designed to help patients with genetic retinitis pigmentosa. [ 24 ] [ 25 ] More than 30 clinical trial participants in Argus II trial launched in 2007 at sites in the U.S. and Europe.
FEATURE 1 Keratoconus and Corneal Cross-Linking BRIEF REVIEWS 3 Porcine model to study primary ocular trauma 4 Argus II Retinal Prosthesis for patients with retinitis pigmentosa 5 Mobile app for calculating superior visual field loss 6 Visian Implantable Collamer Lens for myopia 7 Ophthalmic education in medical school curriculum on the decline
In February 2013, the US Food and Drug Administration approved the use of the Argus II Retinal Prosthesis System , [11] making it the first FDA-approved implant to treat retinal degeneration. The device may help adults with RP who have lost the ability to perceive shapes and movement to be more mobile and to perform day-to-day activities.
Dr. Mark Humayun, who joined the faculty of the Keck School of Medicine of USC in 2001, [16] was a co-inventor of a retinal prosthesis [17] that became the basis for the formation of the company, Second Sight, in 1998.
Consultant Ophthalmologist Paulo Stanga fitted the world's first visual prosthesis, an Argus retinal prosthesis for a patient with age-related macular degeneration to Ray Flynn, 80, in July 2015 at the hospital. He is the first person in the world to have both artificial and natural vision combined. [7]
The ability to give sight to a blind person via a bionic eye depends on the circumstances surrounding the loss of sight. For retinal prostheses, which are the most prevalent visual prosthetic under development (due to ease of access to the retina among other considerations), patients with vision loss due to degeneration of photoreceptors (retinitis pigmentosa, choroideremia, geographic atrophy ...